Thomas J. Spellman III

Thomas J. Spellman III discloses dealings in Alpharma Inc to SEC (Form 4). Over a trading history stretching from 16 July 2007 to 29 December 2008, the count stands at 6 filings.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The newest entry dates from 31 December 2008: a transaction, in Alpharma Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.